Clinical Trial Update: Amodiaquine+Artesunate vs. Artemether-Lumefantrine for Uncomplicated Malaria in Ghanaian Children [Phase 3]

View source ↗

Summary

A Phase 3 trial in Ghanaian children compares amodiaquine plus artesunate with artemether-lumefantrine for malaria; the current status of the trial is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria

Drugs mentioned

• Amodiaquine (Amodiaquine)
• Artemether-lumefantrine (artemether and lumefantrine)
• Artesunate (artesunate)

Snippet

Sponsor: University of Ghana Medical School | Conditions: Uncomplicated Malaria | Phase 3 | Status: UNKNOWN